189 related articles for article (PubMed ID: 37066050)
1. Get Off on the Right Foot: How to Plan an Efficient Leukocytapheresis to Collect T Cells for CAR T-Cell Manufacturing.
Piñeyroa JA; Cid J; Lozano M
Transfus Med Hemother; 2023 Apr; 50(2):98-104. PubMed ID: 37066050
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cell collection efficiency in non-mobilized adult donors for autologous chimeric antigen receptor T-cell manufacturing.
Piñeyroa JA; Cid J; Vlagea A; Carbassé G; Henao P; Bailo N; Ortiz-Maldonado V; Martínez-Cibrian N; Español M; Delgado J; Urbano-Ispizua Á; Lozano M
Vox Sang; 2023 Mar; 118(3):217-222. PubMed ID: 36516201
[TBL] [Abstract][Full Text] [Related]
3. Lack of defined apheresis collection criteria in publicly available CAR-T cell clinical trial descriptions: Comprehensive review of over 600 studies.
Thibodeaux SR; Aqui NA; Park YA; Schneiderman J; Su LL; Winters JL; Zubair AC; Schwartz J; Liu HD;
J Clin Apher; 2022 Jun; 37(3):223-236. PubMed ID: 35085413
[TBL] [Abstract][Full Text] [Related]
4. A guide to the collection of T-cells by apheresis for ATMP manufacturing-recommendations of the GoCART coalition apheresis working group.
Worel N; Holbro A; Vrielink H; Ootjers C; Le Poole K; Beer-Wekking I; Rintala T; Lozano M; Bonig H
Bone Marrow Transplant; 2023 Jul; 58(7):742-748. PubMed ID: 37024570
[TBL] [Abstract][Full Text] [Related]
5. Unstimulated apheresis for chimeric antigen receptor manufacturing in pediatric/adolescent acute lymphoblastic leukemia patients.
Jarisch A; Rettinger E; Sörensen J; Klingebiel T; Schäfer R; Seifried E; Bader P; Bonig H
J Clin Apher; 2020 Sep; 35(5):398-405. PubMed ID: 32750197
[TBL] [Abstract][Full Text] [Related]
6. Depletion of high-content CD14
Wang X; Borquez-Ojeda O; Stefanski J; Du F; Qu J; Chaudhari J; Thummar K; Zhu M; Shen LB; Hall M; Gautam P; Wang Y; Sénéchal B; Sikder D; Adusumilli PS; Brentjens RJ; Curran K; Geyer MB; Mailankhody S; O'Cearbhaill R; Park JH; Sauter C; Slovin S; Smith EL; Rivière I
Mol Ther Methods Clin Dev; 2021 Sep; 22():377-387. PubMed ID: 34514029
[TBL] [Abstract][Full Text] [Related]
7. The Challenge of Variability in Chimeric Antigen Receptor T cell Manufacturing.
Fesnak AD
Regen Eng Transl Med; 2020 Sep; 6(3):322-329. PubMed ID: 33313382
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte apheresis for chimeric antigen receptor T-cell manufacturing in children and young adults with leukemia and neuroblastoma.
Ceppi F; Rivers J; Annesley C; Pinto N; Park JR; Lindgren C; Mgebroff S; Linn N; Delaney M; Gardner RA
Transfusion; 2018 Jun; 58(6):1414-1420. PubMed ID: 29536556
[TBL] [Abstract][Full Text] [Related]
9. Handling the different requirements for commercial and investigational MNC collections by apheresis.
Bobr A; Roberts T; Koepsell S; Williams SM; Schwartz J
Cytotherapy; 2024 Apr; ():. PubMed ID: 38703156
[TBL] [Abstract][Full Text] [Related]
10. Manufacturing chimeric antigen receptor T cells from cryopreserved peripheral blood cells: time for a collect-and-freeze model?
Palen K; Zurko J; Johnson BD; Hari P; Shah NN
Cytotherapy; 2021 Nov; 23(11):985-990. PubMed ID: 34538575
[TBL] [Abstract][Full Text] [Related]
11. A Clinically Applicable Prediction Model to Improve T Cell Collection in Chimeric Antigen Receptor T Cell Therapy.
Jo T; Yoshihara S; Hada A; Arai Y; Kitawaki T; Ikemoto J; Onomoto H; Sugiyama H; Yoshihara K; Obi N; Matsui K; Niwa N; Nakagawa Y; Kanda J; Kondo T; Saida S; Kato I; Hiramatsu H; Adachi S; Takita J; Takaori-Kondo A; Nagao M
Transplant Cell Ther; 2022 Jul; 28(7):365.e1-365.e7. PubMed ID: 35460928
[TBL] [Abstract][Full Text] [Related]
12. Developing lisocabtagene maraleucel chimeric antigen receptor T-cell manufacturing for improved process, product quality and consistency across CD19
Teoh J; Brown LF
Cytotherapy; 2022 Sep; 24(9):962-973. PubMed ID: 35610089
[TBL] [Abstract][Full Text] [Related]
13. Chimeric Antigen Receptor T Cell Therapy Management and Safety: A Practical Tool From a Multidisciplinary Team Perspective.
Marzal-Alfaro MB; Escudero-Vilaplana V; Revuelta-Herrero JL; Collado-Borrell R; Herranz-Alonso A; Sanjurjo-Saez M
Front Oncol; 2021; 11():636068. PubMed ID: 33777790
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting lymphocyte collection efficiency for the manufacture of chimeric antigen receptor T cells in adults with B-cell malignancies.
Tuazon SA; Li A; Gooley T; Eunson TW; Maloney DG; Turtle CJ; Linenberger ML; Connelly-Smith LS
Transfusion; 2019 May; 59(5):1773-1780. PubMed ID: 30729531
[TBL] [Abstract][Full Text] [Related]
15. Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing.
Qayed M; McGuirk JP; Myers GD; Parameswaran V; Waller EK; Holman P; Rodrigues M; Clough LF; Willert J
Cytotherapy; 2022 Sep; 24(9):869-878. PubMed ID: 35718701
[TBL] [Abstract][Full Text] [Related]
16. Apheresis for chimeric antigen receptor T-cell production in adult lymphoma patients.
Harrer DC; Heidenreich M; Fante MA; Müller V; Haehnel V; Offner R; Burkhardt R; Herr W; Edinger M; Wolff D; Thomas S; Brosig A
Transfusion; 2022 Aug; 62(8):1602-1611. PubMed ID: 35851959
[TBL] [Abstract][Full Text] [Related]
17. Radiation and Chimeric Antigen Receptor T-cell Therapy in B-cell Non-Hodgkin Lymphomas.
Deshpande A; Rule W; Rosenthal A
Curr Treat Options Oncol; 2022 Jan; 23(1):89-98. PubMed ID: 35167008
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of leukapheresis for CAR T-cell production in heavily pre-treated pediatric patients.
Hutt D; Bielorai B; Baturov B; Z'orbinski I; Ilin N; Adam E; Itzhaki O; Besser MJ; Toren A; Jacoby E
Transfus Apher Sci; 2020 Aug; 59(4):102769. PubMed ID: 32414613
[TBL] [Abstract][Full Text] [Related]
19. Establishing a robust chimeric antigen receptor T-cell therapy program in Australia: the Royal Prince Alfred Hospital experience.
Velickovic ZM; Rasko JEJ
Cytotherapy; 2022 Jan; 24(1):45-48. PubMed ID: 34521574
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
